Exam 107: Additional Noteworthy Drugs

A patient with a history of heart disease develops pulmonary arterial hypertension (PAH), and the provider is considering prescribing sildenafil [Revatio]. The nurse caring for this patient will perform a careful drug history and notify the provider if the patient is taking which medication?

A nurse is quizzing a nursing student who is preparing to care for a patient with cystic fibrosis. The patient uses inhaled tobramycin [TOBI], dornase alfa [Pulmozyme], ibuprofen, and salmeterol [Serevent Diskus]. Which statement by the student indicates understanding of this patient's drug regimen?

A nurse is caring for a premature infant who has received poractant alfa [Curosurf] 2.5 mL/kg via direct intratracheal instillation to prevent respiratory distress syndrome. The infant demonstrated initial improvement after the dose but has begun to deteriorate. Which treatment will the nurse expect the neonatologist to order?

A nurse counsels a patient who is to begin taking gamma-hydroxybutyrate [Xyrem] for narcolepsy. It is important for the nurse to warn the patient that respiratory depression is a potential risk with concomitant use of:

A patient who has pulmonary arterial hypertension (PAH) is receiving epoprostenol [Flolan] at a rate of 210 ng/min using a portable pump. The patient weighs 70 kg. The patient calls the clinic to report headache, nausea, and vomiting. The nurse will counsel the patient to:

A pregnant patient begins active labor at 30 weeks' gestation. The provider orders dexamethasone 6 mg intramuscularly to be given twice daily for 4 doses. The patient asks the nurse what effect this drug will have on the fetus. The nurse will tell her that the dexamethasone is given to:

An adult patient with sickle cell anemia is being treated for a severe acute crisis with an opioid analgesic, a glucocorticoid, and hydroxyurea. The patient's complete blood count reveals neutrophils 2000/mm³, platelets 85,000/mm³, reticulocytes 85,000/mm³, and a hemoglobin of 4.2 gm/dL. What will the nurse anticipate doing?

The nurse provides teaching for a patient who will begin taking bosentan [Tracleer] for pulmonary arterial hypertension (PAH). Which statement by the patient indicates a need for further teaching about this medication?

A patient with cystic fibrosis uses inhaled tobramycin [TOBI] 300 mg every 12 hours in repeated cycles of 4 weeks on and 4 weeks off. The patient reports hoarseness and tinnitus. The nurse will tell the patient that: